Fritextsökning
Innehållstyper
-
Ny antibiotikaklass når fas III
Ska utvärderas i två studier som behandling av urinvägsinfektion och gonorré.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
A platform for dialogue
As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
They’re all doing it – buying drug research
It is not easy to navigate the complex infrastructure for drug development in Sweden, where various contract players exist alongside the pharmaceutical companies.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Han tar över på Apotekstjänst
Ny vd ska lösa logistikproblematiken
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Academia - a strong player on the lab market
While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...
-
Measurement of calorific content in a matter of minutes
The AC600 calorimeter from Leco uses rapid thermodynamics to analyze calorific content in five minutes.
-
Senzagen i samarbete med Astra Zeneca
Nu inleder Senzagen ett samarbete med Astra Zeneca om att utveckla företagets Gard-teknik för att skilja mellan allergener och irritanter i luftvägarna.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
-
Granskar Mylan-budet
Investeringsbolaget VEB undersöker om budet på svenska Meda bryter mot lagen.
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
Immunterapi väcker uppståndelse
En immunterapi mot leukemi har väckt stor uppmärksamhet efter rapporter om att mer än 90 procent av patienterna med terminal cancer blev bättre.
-
New CEO to Swedish Tillotts Pharma
The Swiss company Tillotts Pharma's newly established Swedish organisation has appointed a CEO from Bayer Scandinavia.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Sanofi sparkar sin vd
Den franska läkemedelskoncernen gör sig av med koncernchefen Christopher A Viebacher.
-
Kärlekens kemi
Urban Fagerholm, docent i farmaci, har på ett vetenskapligt vis i sin nya bok tagit sig an det kanske viktigaste ämnet för mänskligheten – kärleken.
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
BREAKING